FDA Approved: CAMZYOS — Original Application (Myokardia, Inc.)

View source ↗

Summary

FDA approved CAMZYOS (mavacamten) from MyoKardia for adults with symptomatic obstructive hypertrophic cardiomyopathy, marking a new mechanism of action for trea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy
• Obstructive Hypertrophic Cardiomyopathy

Drugs mentioned

• CAMZYOS (MAVACAMTEN)

Snippet

ORIG AP for CAMZYOS (MAVACAMTEN)